Top > Search of International Patents > CELL PREPARATION

CELL PREPARATION

Foreign code F180009429
File No. 2016-003
Posted date Jul 2, 2018
Country WIPO
International application number 2017JP043448
International publication number WO 2018101481
Date of international filing Dec 4, 2017
Date of international publication Jun 7, 2018
Priority data
  • P2016-235286 (Dec 2, 2016) JP
  • P2017-159670 (Aug 22, 2017) JP
Title CELL PREPARATION
Abstract [Problem] To provide a steroid-containing cell preparation exhibiting high therapeutic effects on diseases associated with cartilage tissue as a treatment target.
[Solution] The present invention provides a prophylactic or therapeutic agent for cartilage tissue-associated diseases, the prophylactic or therapeutic agent containing, as an active ingredient, a steroid which contains cultured mesenchymal stem cells.
Scope of claims [claim1]
1. The mesenchymal stem cells in culture comprising as an active ingredient spheroidal, cartilage tissue related disease to a therapeutic agent.
[claim2]
2. An adhesive on the substrate in the cell culture cultureware mesenchymal stem cells spheroidal containing as an active ingredient, a prophylactic or therapeutic agent according to claim 1.
[claim3]
3. Wherein the cartilage tissue-related disease, the deformability of the knee joint disease, traumatic injury, shoulder joint disorders, temporomandibular joint disease, rheumatoid arthritis, bone-cartilage sexualP transecting, osteonecrosis-maturity-free, and the meniscus is selected from the group consisting of damage, a prophylactic or therapeutic agent according to claim 1 or 2.
[claim4]
4. Wherein said mesenchymal stem cells, adipose tissue derived from a human, of any one of claims 1-3 a prophylactic or therapeutic agent.
[claim5]
5. Wherein the base material in the cell culture, polyimide resins, any one of claims 1-4 serivastatin or therapeutic agent.
[claim6]
6. The polyimide resin, a fluorine-containing resin and polyimide resin, according to claim 5 prophylactic or therapeutic agent.
[claim7]
7. To be used by the local HSCT, any one of claims 1-6 serivastatin or therapeutic agent.
  • Applicant
  • ※All designated countries except for US in the data before July 2012
  • NIPPON SHOKUBAI CO., LTD.
  • EDUCATIONAL FOUNDATION OF OSAKA MEDICAL AND PHARMACEUTICAL UNIVERSITY
  • Inventor
  • MAKINO, Akemi
  • NAKATA, Takuma
  • II, Masaaki
IPC(International Patent Classification)

PAGE TOP

close
close
close
close
close
close